Dismiss Modal

Riverside Healthcare’s first priority is to care for the health of our community. As such, we are fully engaged in the changing landscape of Coronavirus or COVID-19. Simultaneously we have been putting the final touches on the Riverside Heart Ball scheduled for March 21.

Sadly, to go forward with our current event date as planned could put our 1,200 attendees at risk during this outbreak. In addition, the Governor of Illinois has mandated that gatherings of 1,000 and more are to be canceled or postponed. We wish we could go forward as planned to honor the generosity demonstrated in sponsorship and tickets in all forms that have made the Heart Ball a record event already.

We have decided that the best course of action is to reschedule the Heart Ball to September 26, 2020 in the same location. We recognize that this will pose logistic challenges for all involved, but we believe it is the best balance to keep the beauty and brilliance of the event, without taking on undue risk for our valued donors and guests.

On behalf of our President & CEO Phil Kambic, our Board of Directors, and our Heart Ball Committee, I thank you for your graciousness in understanding this extraordinary change in this extraordinary time.




Matt McBurnie

Vice President of Institutional Advancement




For additional information about the Heart Ball, please visit www.riversidehealthcare.org/heartball

Related Articles
Read article
Riverside Medical Group Expands Neurology Team

Riverside Neurosciences Institute is pleased to welcome neurologist, Dr. Shuja Sheikh, to Riverside Medical Group. Dr. Sheikh sees patients in Kankakee.

Read article
Seban Liu, DO, Joins Riverside Heart & Vascular Institute

The Riverside Heart & Vascular Institute is pleased to welcome cardiologist Dr. Seban Liu.

Read article
Dr. Cotton performs minimally-invasive carpal tunnel release using Sonex

Riverside Orthopedic Specialists has announced that it now offers carpal tunnel release with UltraGuideCTR by Sonex Health.

Read article
Riverside Heart & Vascular Institute Celebrates 100th TAVR Procedure

The Riverside Heart & Vascular Institute team recently celebrated the successful completion of the 100th Transcatheter Aortic Valve Replacement (TAVR) procedure, a minimally invasive alternative to open-heart surgery for treating aortic stenosis.